Adverum Biotechnologies Inc (ADVM)
6.04
+0.29
(+5.04%)
USD |
NASDAQ |
Nov 22, 16:00
6.05
+0.01
(+0.17%)
After-Hours: 20:00
Adverum Biotechnologies Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.38M |
March 31, 2024 | -119.74M |
December 31, 2023 | |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.009M |
March 31, 2021 | -1.694M |
December 31, 2020 | 0.245M |
September 30, 2020 | -203.72M |
June 30, 2020 | 0.101M |
March 31, 2020 | -140.92M |
December 31, 2019 | -25.76M |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.134M |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 0.002M |
September 30, 2018 | -0.001M |
June 30, 2018 | 0.003M |
March 31, 2018 | -70.19M |
December 31, 2017 | -16.52M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | -138.95M |
December 31, 2014 | 0.52M |
September 30, 2014 | -116.97M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-203.72M
Minimum
Sep 2020
0.38M
Maximum
Jun 2024
-32.74M
Average
--
Median
Sep 2021
Stock Buybacks (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | -11.79M |
Cassava Sciences Inc | -- |
Regenxbio Inc | -0.246M |
Editas Medicine Inc | 0.00 |
Apellis Pharmaceuticals Inc | 0.00 |